Oncology

Latest News

FDA Approved | Image credit: chrisdorney – stock.adobe.com
Teliso-V Approved to Treat Advanced NSCLC With High c-Met Protein Overexpression

May 14th 2025

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung cancer (NSCLC) with high c-Met overexpression, offering new hope.

While CTCs were identified regardless of disease stage, the current study identified large variations in the presence of CTCs between nonmetastatic and metastatic disease | Image Credit: Innovative Creation - stock.adobe.com
Flow Cytometry Can Reliably Identify CTC in Melanoma

May 14th 2025

Jack & Sheryl Morris Cancer Center | Image credit: RWJBarnabas Health
New Jersey’s First Freestanding Cancer Hospital Opens in New Brunswick

May 14th 2025

At 3 months, hospitalizations among patients enrolled in RSM were 19% lower vs historical controls. | Image Credit: Nuttapong punna - stock.adobe.com
Remote Symptom Monitoring Linked to Reduced Hospitalization Risk for Patients With Cancer

May 14th 2025

Offline data augmentation can significantly enhance deep learning techniques, improving classification performance compared to models trained solely on original clinician skin images. | Image Credit: Alexander - stock.adobe.com
Optimized Deep Learning Model Classifies Smartphone Images of Malignant Skin Lesions

May 12th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Oncology Care Model: Measuring Value
May 21st 2019

Oncology Care Model: Measuring Value

Evolving Versions of the Oncology Care Model
May 21st 2019

Evolving Versions of the Oncology Care Model

Novel Therapies & The OCM: Treatment Decisions
May 21st 2019

Novel Therapies & The OCM: Treatment Decisions

Oncology Care Model: Counseling Patients
May 21st 2019

Oncology Care Model: Counseling Patients

Opportunities of the Oncology Care Model
May 21st 2019

Opportunities of the Oncology Care Model

Oncology Care Model: Measuring Performance
May 21st 2019

Oncology Care Model: Measuring Performance

Practice Pathways Under the Oncology Care Model
May 21st 2019

Practice Pathways Under the Oncology Care Model

Oncology Care Model: Multidisciplinary Care
May 21st 2019

Oncology Care Model: Multidisciplinary Care

Oncology Care Model: 2-Sided Financial Risk
May 21st 2019

Oncology Care Model: 2-Sided Financial Risk

A Current Look at the Oncology Care Model
May 21st 2019

A Current Look at the Oncology Care Model

Barry Russo: Alliances Between Practices Are Invaluable to the Future of Cancer Care
May 19th 2019

Barry Russo: Alliances Between Practices Are Invaluable to the Future of Cancer Care

Alliances are going to help community oncology participate in things that, as individual practices, they don‘t have the opportunity to do, said Barry Russo, chief executive officer of The Center for Cancer and Blood Disorders.
Feyi Olopade Ayodele on the Importance of Early Cancer Detection in a Value-Based Care System
May 17th 2019

Feyi Olopade Ayodele on the Importance of Early Cancer Detection in a Value-Based Care System

With CancerIQ, we’re really going to be helping push population health into the oncology arena where we can hopefully predict and preempt this very costly and devastating disease well in advance, says Feyi Olopade Ayodele, MBA, chief executive officer at CancerIQ.
David Ortiz Highlights Changes in Care as a Result of OCM
May 16th 2019

David Ortiz Highlights Changes in Care as a Result of OCM

The Oncology Care Model (OCM) has set off a ripple of change in cancer care that extends beyond the patients who are in the model, said David Ortiz, OCM program director at Montefiore Einstein Center for Cancer Care.
Physicians More Likely to Order Cancer Screening in the Morning
May 14th 2019

Physicians More Likely to Order Cancer Screening in the Morning

Jaime Rosenberg
Patients with primary care appointments in the morning were more likely to have orders for and receive recommended breast and colorectal cancer screenings.
Connecting Cancer Practices to Share Data, Deliver Better Care, Identify Best Practices
May 14th 2019

Connecting Cancer Practices to Share Data, Deliver Better Care, Identify Best Practices

Outcomes for patients with cancer are continuously improving, but the increasingly complex healthcare system, new payment and delivery models that place more risk on practices, and rising costs of therapies has made it difficult for independent oncology practices to thrive and survive. However, independent practices present an important part of cancer care, delivering care to patients who are not near large hospital-based systems at lower costs.
Beth Wittmer Details the Components of a Care Management Team
May 14th 2019

Beth Wittmer Details the Components of a Care Management Team

Pharmacists, social support services, an information technology team, and financial counselors all come together to encompass the care for the patient, says Beth Wittmer, RN, OCN, manager of care management at Florida Cancer Specialists and Research Institute.
Dr Ray Page Details Using Triage Pathways and Scaling Them Across Multiple Practices
May 10th 2019

Dr Ray Page Details Using Triage Pathways and Scaling Them Across Multiple Practices

Triage pathways can transform practices and save practices and CMS money by keeping people out of the emergency department and hospital, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.
Dr Michael Kolodziej Weighs the Pros and Cons of Government Influence on Payment Reform
May 6th 2019

Dr Michael Kolodziej Weighs the Pros and Cons of Government Influence on Payment Reform

Some of the health policies coming out of Washington, DC, are clever, but there might be too much coming out for practices to keep up with, said Michael Kolodziej, MD, vice president and chief innovation officer at ADVI Health, Inc.
Site Logo
May 6th 2019

Beyond Satisfaction Scores: Exploring Emotionally Adverse Patient Experiences

Laura M. Holdsworth, PhD Dani L. Zionts, MScPH Karen Marie De Sola-Smith, PhD Melissa Valentine, PhD Marcy D. Winget, PhD Steven M. Asch, MD
This study explores the causes of emotionally adverse patient experiences in cancer care and presents a taxonomy for analyzing free-text patient data.
Treatment Could Prevent Patients With Cancer From Experiencing Jawbone Damage After Oral Surgery
May 4th 2019

Treatment Could Prevent Patients With Cancer From Experiencing Jawbone Damage After Oral Surgery

Laura Joszt, MA
Patients with cancer who receive high doses of bisphosphonates, used to treat bone cancer, can experience jaw damage. New preclinical research published in Bone Science Direct could prevent these patients from experiencing this loss of jawbone tissue after routine oral surgery.
Feyi Olopade Ayodele Highlights Positive Outcomes of Genetic Screening for Cancer
May 4th 2019

Feyi Olopade Ayodele Highlights Positive Outcomes of Genetic Screening for Cancer

Patients who adhere to a CancerIQ cancer prevention plan, or cancer survivorship plan, are more likely to catch a cancer before it grows beyond 1 centimeter, says Feyi Olopade Ayodele, MBA, chief executive officer at CancerIQ.
Barry Russo Explains How Artificial Intelligence Programs Can Simplify Cancer Care
May 3rd 2019

Barry Russo Explains How Artificial Intelligence Programs Can Simplify Cancer Care

An artificial intelligence system can digest what would take a person 29 hours to read in about 30 seconds, so everything is right in front of providers at the point of care, says Barry Russo, chief executive officer of The Center for Cancer and Blood Disorders.
Site Logo
May 2nd 2019

Cancer Moonshot Agenda Continues on With the Biden Cancer Initiative

Laura Joszt, MA
During a session at Asembia’s 15th annual Specialty Pharmacy Summit, Greg Simon, president, Biden Cancer Initiative, outlined commitments that came out of the Cancer Moonshot, the work of the Biden Cancer Initiative, and ongoing challenges that patients with cancer face.
Matt Farber Discusses Pharmacist Role in Managing Cancer Care Costs
May 2nd 2019

Matt Farber Discusses Pharmacist Role in Managing Cancer Care Costs

New technologies are enabling pharmacists to play a bigger role in managing overall care delivery and the cost of care for patients with cancer, explained Matt Farber, MA, senior director of Patient Care and Advocacy for Walgreens.
Dr Stephen Grubbs on the Refresh of ASCO's PCOP Model
May 2nd 2019

Dr Stephen Grubbs on the Refresh of ASCO's PCOP Model

Stephen Grubbs, MD, vice president of clinical affairs at the American Society of Clinical Oncology, explains what stakeholders can expect from the new updates to the Patient-Centered Oncology Payment (PCOP) model, as well as some key differences between PCOP and the Oncology Care Model.
Dr Blase Polite on the State of the OCM
May 1st 2019

Dr Blase Polite on the State of the OCM

Blase Polite, MD, associate professor of medicine and the executive director for accountable care at the University of Chicago, discusses why he chose to focus on the state of the Oncology Care Model at the April 25 meeting of the Institute for Value-Based Medicine.
Site Logo
May 1st 2019

The Promise of Specialty Oncology Innovations in the Drug Pipeline

Silas Inman
The oncology drug pipeline has experienced rapid growth over the past decade, driven by innovation in cell therapies, immunotherapy, and precision medicine, according to a specialty pipeline update presentation at Asembia's 15th annual Specialty Pharmacy Summit, held April 29 to May 2 in Las Vegas.
Dr Bryan Loy on Mandatory Bundled Payments and the Role of Payers
April 30th 2019

Dr Bryan Loy on Mandatory Bundled Payments and the Role of Payers

Payers, providers, and other stakeholders have to come together to figure out how to make a better patient member experience for those who are fighting cancer, said Bryan Loy, MD, physician lead, oncology, laboratory, and personalized medicine, Humana.
Abra Kelson Explains How Social Workers Help Patients Overcome Challenges
April 28th 2019

Abra Kelson Explains How Social Workers Help Patients Overcome Challenges

The standard treatment isn’t always right for everyone, and part of a social worker’s job as a member of the care team is to understand the patient’s goals and what treatment is the right fit for them, said Abra Kelson, MSW, LSWA-IC, medical social work supervisor, Northwest Medical Specialties.
Feyi Olopade Ayodele: CancerIQ Eases Access to Genetic Screening in Community Cancer Centers
April 26th 2019

Feyi Olopade Ayodele: CancerIQ Eases Access to Genetic Screening in Community Cancer Centers

CancerIQ has automated a lot of time-consuming steps to allow operationally efficient community cancer centers a way of offering genetic screening in a profitable manner, said Feyi Olopade Ayodele, MBA, chief executive officer at CancerIQ.
<1
...
252627282930313233
...
185>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo